We're seeing major advances vs pancreatic cancer. Today @NEJM data for daraxonrasib @RevMedicines https://
nejm.org/doi/full/10.10
56/NEJMoa2505783?query=featured_home
…
Context for this first-in-class molecular glue https://
nejm.org/doi/full/10.10
56/NEJMoa2505783?query=featured_home
…

→ View original post on X — @erictopol,